Penserra Capital Management LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 214 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$34,000
-22.7%
4,810
+0.9%
0.00%0.0%
Q2 2021$44,000
+2.3%
4,765
+1.7%
0.00%0.0%
Q1 2021$43,000
+26.5%
4,685
+18.8%
0.00%0.0%
Q4 2020$34,000
+112.5%
3,945
+175.5%
0.00%0.0%
Q3 2020$16,0001,4320.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 200,000$998,0000.36%
Green Alpha Advisors, LLC 72,647$363,0000.24%
Skaana Management L.P. 227,851$1,137,0000.18%
SEVEN EIGHT CAPITAL, LP 196,351$980,0000.18%
Defender Capital, LLC. 103,038$514,0000.16%
Skaana Management L.P. 206,300$1,029,0000.16%
WASATCH ADVISORS LP 4,926,125$24,581,0000.10%
Parametrica Management Ltd 16,183$81,0000.08%
Cedar Brook Financial Partners, LLC 54,500$272,0000.07%
Hennion & Walsh Asset Management, Inc. 274,703$1,371,0000.07%
View complete list of INOVIO PHARMACEUTICALS INC shareholders